Tag: 2026
Eli Lilly Expands Oncology Ambitions with Up to $2.3 Billion Ajax Therapeutics Acquisition
Eli Lilly has announced a major strategic move to strengthen its oncology portfolio through the acquisition of Ajax Therapeutics in a deal valued at...
India–New Zealand FTA Opens Zero-Duty Pharma Gateway, Boosting ‘Made in India’ Healthcare Exports
In a significant boost for India’s healthcare and pharmaceutical ecosystem, the newly signed India–New Zealand Free Trade Agreement (FTA) is set to create powerful...
A Global Pediatric Milestone: WHO Pre qualifies First Malaria Treatment for Newborns and Young Infants
In a landmark step for global child health, the World Health Organization (WHO) has prequalified the world’s first malaria treatment specifically designed for newborns...
Cipla Secures U.S. FDA Approval for First AB-Rated Generic Therapeutic Equivalent to Ventolin® HFA
The United States Food and Drug Administration (USFDA) has granted final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol,...
Novo Nordisk’s Etavopivat Cracks Phase 3 Goals: A Potential New Standard of Care for Sickle Cell Disease
Novo Nordisk’s Etavopivat hits the mark in Pivotal Sickle Cell Study. Etavopivat, an oral, once-daily pyruvate kinase-R (PKR) activator displayed supercilious results showing 27%...